Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Gross margin of Sobi 2009-2020

The gross margin of Swedish biopharmaceutical company Sobi was down at the lowest point in 2011 at 51 percent, but then generally increased the following years. In 2020, the gross margin of Sobi stood at almost 80 percent. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases.

Gross margin of Sobi from 2009 to 2020

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2021

Region

Sweden

Survey time period

2009 to 2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Biogen"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.